Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus

This publication has 32 references indexed in Scilit:

• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
  Archives of internal medicine (1960), 1988
• Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia
  Annals of Internal Medicine, 1987
• Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics
  Atherosclerosis, 1985
• Metabolism of Low-Density Lipoprotein from Patients with Diabetic Hypertriglyceridemia by Cultured Human Skin Fibroblasts
  Diabetes, 1985
• Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
  Journal of Clinical Investigation, 1984
• Diabetes as an atherogenic factor
  Progress in Cardiovascular Diseases, 1984
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study
  Diabetes Care, 1983
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity
  Diabetes, 1982
• Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductase
  Atherosclerosis, 1982
• THE EFFECT OF LARGE DOSES OF NICOTINIC ACID ON CIRCULATING LIPIDS AND CARBOHYDRATE TOLERANCE
  The Lancet Healthy Longevity, 1959